Drug profile · INN
doxorubicin hydrochloride (as pegylated liposomal)
CAELYX
- Patents linked
- 0
- News articles
- 0
Quick answer
doxorubicin hydrochloride (as pegylated liposomal) (CAELYX) is an FDA-listed pharmaceutical active ingredient. Associated with BAXTER HEALTHCARE PTY LTD.
Key facts
INN doxorubicin hydrochloride (as pegylated liposomal)
Brand CAELYX
Originator BAXTER HEALTHCARE PTY LTD
Frequently asked questions
What is doxorubicin hydrochloride (as pegylated liposomal)?
doxorubicin hydrochloride (as pegylated liposomal) (CAELYX) is an FDA-listed pharmaceutical active ingredient. Associated with BAXTER HEALTHCARE PTY LTD.
What is the brand name for doxorubicin hydrochloride (as pegylated liposomal)?
CAELYX is a marketed brand name for doxorubicin hydrochloride (as pegylated liposomal). Check FDA Drugs@FDA for the current US label holder and prescribing information.